GE's Sales Decline 3%, Hit by Supply-Chain Woes 
 

The conglomerate projected a return to sales growth this year as its aviation business begins to recover.

 
American Express Boosts Forecasts as Credit Card Spending Sets Record 
 

For the full year, American Express expects to generate revenue growth in the range of 18% to 20% and earnings per share of $9.25 to $9.65.

 
Elon Musk Urges McDonald's to Accept Dogecoin for Payment 
 

The Tesla CEO tweeted that he would eat a Happy Meal on TV if the fast-food giant began accepting the cryptocurrency.

 
FTC Sues to Block Lockheed Martin Acquisition of Aerojet Rocketdyne 
 

The Federal Trade Commission says the proposed $4.4 billion purchase would allow the defense giant to control access to parts needed to build missile engines.

 
Casino Operator Bally's Shares Jump on Standard General Buyout Offer 
 

The stock soars more than 20% after Standard General offers to buy the shares it doesn't already own in a deal that values the company at $2.07 billion.

 
Kroger Workers Approve New Contract After Nine-Day Strike 
 

More than 8,000 unionized workers ratify a contract that gives them wage increases and better healthcare and pension benefits.

 
AMC in Advanced Talks to Refinance Debt as Meme-Stock Luster Fades 
 

Shares and bonds of AMC Entertainment have sunk this year, reversing most of their gains since the cinema chain became a meme-stock favorite and coming as the company steps up efforts to ink a refinancing deal.

 
Nvidia stock falls after report says company could give up on Arm deal 
 

Shares of Nvidia Corp. were declining in Tuesday trading after a report indicated that the company is preparing to give up on its planned purchase of Arm Ltd. from SoftBank Group Corp.

 
GM Pumps More Money Into EVs, Picks Michigan for Big Investment 
 

The Detroit auto maker doubles down on electric-truck production and plans an battery-cell factory with LG Energy Solution, creating 4,000 new jobs in the Great Lakes state.

 
Johnson & Johnson Posts Higher Quarterly Sales Despite Some Pandemic-Related Pains 
 

The health company finished 2021 with its strongest quarter to date for Covid-19 vaccine sales, contributing to year-over-year revenue growth across its operations as it prepares to separate its consumer-health division.

 
 

(END) Dow Jones Newswires

January 25, 2022 13:15 ET (18:15 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.